Fox Run Management’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172K | Buy |
+18,363
| New | +$172K | 0.03% | 767 |
|
|
2025
Q1 | – | Sell |
-16,355
| Closed | -$216K | – | 1204 |
|
|
2024
Q4 | $216K | Sell |
16,355
-13,601
| -45% | -$180K | 0.04% | 737 |
|
|
2024
Q3 | $577K | Sell |
29,956
-25,879
| -46% | -$498K | 0.13% | 297 |
|
|
2024
Q2 | $1.15M | Buy |
+55,835
| New | +$1.15M | 0.22% | 139 |
|
|
2023
Q4 | – | Sell |
-15,320
| Closed | -$222K | – | 1002 |
|
|
2023
Q3 | $222K | Buy |
+15,320
| New | +$222K | 0.07% | 534 |
|
|
2023
Q2 | – | Sell |
-13,214
| Closed | -$279K | – | 939 |
|
|
2023
Q1 | $279K | Buy |
+13,214
| New | +$279K | 0.09% | 426 |
|